3rd July 2026, Friday

TechPharus

Latest Posts

HealthTech News

  • Immature immune cells predict chances of survival following a heart attack
    on July 3, 2026 at 5:40 pm

    In the event of a severe heart attack, immature immune cells are released into the bloodstream from the bone marrow. A research team led by the University of Münster has demonstrated that the maturity level of neutrophils can be used to determine the short-term risk of death, and this can be assessed through a simple blood test. These findings have been published in the journal Nature Cardiovascular Research.

  • Zebrafish brains reveal alternate route for senses to the forebrain shared with mammals
    on July 3, 2026 at 4:40 pm

    Line up the brains of a fish, bird and a mammal, and something unexpected comes up. You do not see three different answers to the problem of making sense of the world. You see one answer, tilted three different ways. “You can really see it’s almost like a continuum,” says Emre Yaksi, a professor at the Kavli Institute for Systems Neuroscience in Trondheim.

  • 1 in 5 adults make health decisions based on what they see on social media despite widespread mistrust
    on July 3, 2026 at 4:20 pm

    Every few scrolls, another health expert appears on the screen. While some are genuinely qualified, others simply sound convincing enough to pass as one. With AI-generated content flooding feeds, avoiding such advice is becoming increasingly difficult. The way people access health advice has shifted, and for many, social media might be a primary source of information. We need to keep up with its impact because, unlike traditional health channels, these platforms often lack strong editorial checks, making it easier for misinformation to spread.

  • Molecules link lower weight babies and chronic diseases
    on July 3, 2026 at 4:00 pm

    Researchers have long sought to discover why babies who weigh less than expected at birth, a condition known as small for gestational age, or SGA, are at higher risk for heart, lung and metabolic diseases as adults.

  • AI tool improves prediction of who will respond to cancer immunotherapy drugs
    on July 3, 2026 at 3:40 pm

    Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others. But these drugs work for only a subset of patients, with few indications why—a knowledge gap that has detrimental effects on patient prognosis, clinical trial recruitment and research that could lead to new therapies.